Search Results - "APPIERTO, V"

Primary tumor somatic mutations in the blood of women with ductal carcinoma in situ of the breast by Di Cosimo, S., Appierto, V., Silvestri, M., Ortolan, E., De Cecco, L., Veneroni, S., Pruneri, G., Vingiani, A., Belfiore, A., Scaperrotta, G., Folli, S., Daidone, M.G.

Get full text

Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy by Ortolan, E., Appierto, V., Silvestri, M., Miceli, R., Veneroni, S., Folli, S., Pruneri, G., Vingiani, A., Belfiore, A., Cappelletti, V., Vismara, M., Dell'Angelo, F., De Cecco, L., Bianchi, G.V., de Braud, F.G., Daidone, M.G., Di Cosimo, S.

“…As neoadjuvant chemotherapy (NAC) is increasingly used in triple-negative breast cancer (TNBC), we investigated the value of circulating tumor DNA (ctDNA) for…”
Get full text

Circulating tumor DNA and disease recurrence in early stage breast cancer: From a case-control study to a prospective longitudinal trial by Di Cosimo, S., Appierto, V., Ortolan, E., Dell’Angelo, F., Silvestri, M., Bianchi, G., Folli, S., De Cecco, L., Pruneri, G., Daidone, M.G.

Get full text

PLAB induction in fenretinide-induced apoptosis of ovarian cancer cells occurs via a ROS-dependent mechanism involving ER stress and JNK activation by Appierto, Valentina, Tiberio, Paola, Villani, Maria Grazia, Cavadini, Elena, Formelli, Franca

“…Fenretinide [N-(4-hydroxyphenyl)-retinamide (4HPR)] is a synthetic retinoid with antitumor activity that induces apoptosis in various types of cancer cell. We…”
Get full text

1026 AF1q – a Novel Mediator of Basal and 4-HPR-Induced Apoptosis in Ovarian Cancer Cells by Appierto, V, Tiberio, P, Cavadini, E, Callari, M, Daidone, M.G

Get full text

1025 Targeting Malignant Peritoneal Mesothelioma – Therapeutic Potential of Synthetic Retinoids by Tiberio, P, Appierto, V, Santilli, G, Cavadini, C, De Marco, C, Zaffaroni, N, Daidone, M.G

Get full text

Analysis of gene expression identifies PLAB as a mediator of the apoptotic activity of fenretinide in human ovarian cancer cells by APPIERTO, V, VILLANI, M. G, FORMELLI, F, CAVADINI, E, GARIBOLDI, M, DE CECCO, L, PIEROTTI, M. A, LAMBERT, J. R, REID, J, TIBERIO, P, COLOMBO, N

“…Fenretinide (4-HPR) is a synthetic retinoid with antitumor activity, which induces apoptosis in cancer cell lines of different histotypes. To identify genes…”
Get full text

Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarian tumour cell line by APPIERTO, V, CAVADINI, E, PERGOLIZZI, R, CLERIS, L, LOTAN, R, CANEVARI, S, FORMELLI, F

“…We investigated whether the efficacy of fenretinide (HPR) against ovarian tumours may be limited by induction of resistance. The human ovarian carcinoma cell…”
Get full text

Assessing genomic stability of pluripotent stem cells: why, when, and how by Ntai, A., La Spada, A., Valle, M., Sconda, A., Carlus-Charles, H., Appierto, V.

Get full text

91OCirculating tumor DNA and disease recurrence in early stage breast cancer: From a case-control study to a prospective longitudinal trial by Di Cosimo, S, Appierto, V, Ortolan, E, Dell’Angelo, F, Silvestri, M, Bianchi, G, Folli, S, De Cecco, L, Pruneri, G, Daidone, M G

Get full text

Circulating Biomarkers for Prediction of Treatment Response by Cappelletti, Vera, Appierto, Valentina, Tiberio, Paola, Fina, Emanuela, Callari, Maurizio, Daidone, Maria Grazia

“…For cancer management, predicting and monitoring response to treatment and disease progression longitudinally is crucial due to changes in tumor biology and…”
Get full text

Abstract P2-02-19: Circulating tumor DNA detection anticipates disease recurrence in early stage breast cancer: A pilot study generating an observational confirmatory trial by Daidone, MG, Di Cosimo, S, Veneroni, S, Cascone, F, De Cecco, L, Dugo, M, Folli, S, Bianchi, GV, Tamborini, E, Busico, A, Appierto, V

“…Abstract Sensitive tumor biomarkers able to monitor disease progression would contribute to post-surgical treatment decision making in early breast cancer. We…”
Get full text

Abstract P4-01-03: Withdrawn by Di Cosimo, S, Appierto, V, Pizzamiglio, S, Baselga, J, Piccart, M, Huober, J, Izquierdo, M, de la Pena, L, Hilbers, F, de Azambuja, E, Untch, M, Pusztai, L, Pritchard, KI, Nuciforo, P, Salomon, AV, Symmans, FW, Apolone, G, de Braud, F, Verderio, P, Daidone, MG

“…Abstract This abstract was withdrawn by the authors. Citation Format: Di Cosimo S, Appierto V, Pizzamiglio S, Baselga J, Piccart M, Huober J, Izquierdo M, de…”
Get full text

It's not the quality but the quantity: tumor mutation spectrum and response to neoadjuvant therapy in triple negative breast cancer by Di Cosimo, S., Dugo, M., Appierto, V., Cavalieri, S., Angeloni, V., Galli, G., Bregni, G., Cappelletti, V., Paolini, B., Perrone, F., Tiberio, P., de Braud, F.

Get full text

Abstract S3-02: Plasma microRNA levels for predicting therapeutic response to neoadjuvant treatment in HER2-positive breast cancer: Results from Neo-ALTTO by Di Cosimo, S, Appierto, V, Tiberio, P, Verderio, P, Pizzamiglio, S, Bottelli, S, Iorio, M, Baselga, J, Piccart, M, Huober, J, Brase, J, de la Pena, L, Fumagalli, D, de Azambuja, E, de Braud, F, Daidone, MG

“…Abstract Background A significant portion of breast cancer patients treated in the neoadjuvant setting does not achieve a pathological complete response (pCR)…”
Get full text

Expression of the Epidermal Growth Factor Receptor Gene in Human Intestinal Metaplasia: A Preliminary Report by Granelli, P., Fichera, G., Zennaro, F., Siardi, C., Ruberto, F. De, Fregoni, F., Appierto, V., Buffa, R., Ferrero, S., Biunno, I.

“…Background: The role of growth factors/receptors in the etiopathology and/or development of gastric cancer has recently come under scrutiny, since…”
Get full text

Involvement of c-Fos in fenretinide-induced apoptosis in human ovarian carcinoma cells by Appierto, V, Villani, M G, Cavadini, E, Lotan, R, Vinson, C, Formelli, F

“…Fenretinide (HPR), a synthetic retinoid that exhibits lower toxicity than other retinoids, has shown preventive and therapeutic activity against ovarian…”
Get full text

Role of retinoic acid receptor overexpression in sensitivity to fenretinide and tumorigenicity of human ovarian carcinoma cells by Pergolizzi, Rossana, Appierto, Valentina, Crosti, Mariacristina, Cavadini, Elena, Cleris, Loredana, Guffanti, Alessandro, Formelli, Franca

“…The role of retinoic acid receptor (RAR) expression in sensitivity to N‐(4‐hydroxyphenyl)retinamide (4HPR or fenretinide) as well as on the tumorigenicity of…”
Get full text

Decrease in drug accumulation and in tumour aggressiveness marker expression in a fenretinide-induced resistant ovarianumour cell line by Appierto, V, Cavadini, E, Pergolizzi, R, Cleris, L, Lotan, R, Canevari, S, Formelli, F

“…We investigated whether the efficacy of fenretinide (HPR) against ovarian tumours may be limited by induction of resistance. The human ovarian carcinoma cell…”
Get full text

Isolation of a Pancreas-Specific Gene Located on Human Chromosome 14q31: Expression Analysis in Human Pancreatic Ductal Carcinomas by Biunno, Ida, Appierto, Valentina, Cattaneo, Monica, Leone, Biagio Eugenio, Balzano, Gianpaolo, Socci, Carlo, Saccone, Salvatore, Letizia, Andreozzi, Valle, Giuliano Della, Sgaramella, Vittorio

“…We have isolated a novel cDNA (SEL1L) that shows sequence similarities to SEL-1, a gene identified as an extragenic suppressor of thelin-12hypomorphic mutant…”
Get full text